This is the authors' abstract. We don't add key points for this paper.
The selection of linkers and payloads plays a crucial role in determining the therapeutic indices of antibody–drug conjugates (ADCs). 1 Valine–citrulline (Val–Cit) coupled with a self-immolative ρ-aminobenzyl (PAB) spacer as a cleavable dipeptide linker, designated as “VC linker” in this letter, has been popularly used in ADC conjugation. 1 However, VC linker is highly hydrophobic 2 and, together with hydrophobic payloads at high DARs (drug-to-antibody ratios), may turn ADC molecules that have hydrophilic parts in their antibody portions, into aggregation-prone “surfactant-like” structures. Aggregation of ADCs in vivo may lead to accelerated plasma clearance, suboptimal efficacy, and increased toxicity. 2 , 3
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Shao et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: